Portfolio Strategies’s Amgen AMGN Stock Holding History

Portfolio Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-175	Closed	-$30K	–	237
2018 Q1	$30K	Hold	175	–	–	0.02%	95
2017 Q4	$30K	Buy	+175	New	+$31K	0.02%	102

Other funds holding AMGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Portfolio Strategies's AMGN Position: Q2 2018 in Review

Portfolio Strategies sold out of Amgen (AMGN) in Q2 2018, closing a stake of 175 shares — an estimated $30K sold.

Portfolio Strategies first reported a position in AMGN in Q4 2017 and held it in 2 quarters. The position peaked at $30K in Q1 2018. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

Portfolio Strategies reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
Portfolio Strategies sold 175 Amgen shares in Q2 2018, an estimated $30K.
Portfolio Strategies first reported a position in Amgen in Q4 2017 and held it in 2 quarters.
Portfolio Strategies's Amgen position peaked at $30K in Q1 2018.
1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Portfolio Strategies's 13F filing for Q2 2018, filed 25 Sep 2018.